PRECORSE study: Seroprevalence of severe acute respiratory syndrome coronavirus 2 in the first trimester of pregnancy during the first wave of the COVID-19 pandemic and subsequent pregnancy complications-A cohort study

Int J Gynaecol Obstet. 2023 Oct;163(1):326-328. doi: 10.1002/ijgo.15027. Epub 2023 Aug 8.

Adriana Aquise^{1

2}, Nieves Rayo^{1

2}, Irene Fernández-Buhigas^{1

2}, Ana Alfonso³, Natalia Pagola³, Miguel Rodriguez^{1

2}, Laura de Miguel⁴, Irene Santacruz⁴, Santiago Valor⁴, Liona C Poon⁵, María M Gil^{1

2}, Belén Santacruz^{1

2}

¹ Department of Obstetrics and Gynecology, Hospital Universitario de Torrejón, Madrid, Spain.
² School of Medicine, Universidad Francisco de Vitoria, Madrid, Spain.
³ Department of Obstetrics and Gynecology, Hospital Universitario de Fuenlabrada, Madrid, Spain.
⁴ Synlab laboratory, Madrid, Spain.
⁵ Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR.

No abstract available

Keywords: COVID-19; SARS-CoV-2; antibodies; coronavirus; immunoglobulin; pandemic; pregnancy; seroprevalence.

MeSH terms